83.60
price down icon0.80%   -0.67
after-market アフターアワーズ: 83.14 -0.46 -0.55%
loading
前日終値:
$84.27
開ける:
$84.01
24時間の取引高:
2.02M
Relative Volume:
0.52
時価総額:
$48.51B
収益:
$5.88B
当期純損益:
$1.34B
株価収益率:
35.59
EPS:
2.3489
ネットキャッシュフロー:
$799.60M
1週間 パフォーマンス:
+0.17%
1か月 パフォーマンス:
-3.74%
6か月 パフォーマンス:
+4.50%
1年 パフォーマンス:
+20.81%
1日の値動き範囲:
Value
$83.16
$84.69
1週間の範囲:
Value
$83.16
$86.19
52週間の値動き範囲:
Value
$65.94
$87.89

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1113)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

EW を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
83.60 48.90B 5.88B 1.34B 799.60M 2.3489
Medical Devices icon
ABT
Abbott Laboratories
108.27 189.14B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
BSX
Boston Scientific Corp
93.61 138.74B 19.35B 2.78B 3.82B 1.8696
Medical Devices icon
SYK
Stryker Corp
354.57 136.52B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
100.69 129.06B 34.76B 4.79B 5.21B 3.7017

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-09 アップグレード TD Cowen Hold → Buy
2025-12-18 アップグレード JP Morgan Neutral → Overweight
2025-11-03 アップグレード Raymond James Mkt Perform → Outperform
2025-10-29 アップグレード Jefferies Hold → Buy
2025-10-29 アップグレード Wolfe Research Underperform → Peer Perform
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-10-07 アップグレード Evercore ISI In-line → Outperform
2025-07-29 アップグレード BTIG Research Neutral → Buy
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
Jan 26, 2026

Judge: Edwards/Jenavalve would create “total monopoly” - Global Competition Review

Jan 26, 2026
pulisher
Jan 25, 2026

Sector Gamma AS Acquires 30,980 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Jan 25, 2026
pulisher
Jan 25, 2026

Mitsubishi UFJ Trust & Banking Corp Sells 25,276 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Jan 25, 2026
pulisher
Jan 24, 2026

Profit Review: Will Edwards Lifesciences Corporation outperform its industry peersMarket Rally & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 23, 2026

Heart Valve Deal Was Blocked Over Innovation Concerns - Law360

Jan 23, 2026
pulisher
Jan 23, 2026

Edwards Lifesciences (NYSE:EW) Issues FY 2026 Earnings Guidance - MarketBeat

Jan 23, 2026
pulisher
Jan 21, 2026

What to expect from Edwards Lifesciences' Q4 2025 earnings report - MSN

Jan 21, 2026
pulisher
Jan 21, 2026

Universal Beteiligungs und Servicegesellschaft mbH Raises Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Allstate Corp Buys Shares of 21,090 Edwards Lifesciences Corporation $EW - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

VIX Spike: Can GBFH sustain earnings growthJuly 2025 Reactions & Daily Profit Maximizing Tips - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Aug Action: Is Edwards Lifesciences Corporation showing insider buyingQuarterly Investment Review & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Edwards Lifesciences (EW) Receives New Analyst Target Price from Piper Sandler | EW Stock News - GuruFocus

Jan 20, 2026
pulisher
Jan 20, 2026

Stifel raises Edwards Lifesciences stock price target to $110 on TAVR growth - Investing.com Canada

Jan 20, 2026
pulisher
Jan 20, 2026

Edwards Lifesciences Corp. Still Trying To Regain Footing - AOL.com

Jan 20, 2026
pulisher
Jan 19, 2026

Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential? - Yahoo Finance

Jan 19, 2026
pulisher
Jan 19, 2026

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing? - Yahoo Finance

Jan 19, 2026
pulisher
Jan 19, 2026

Edwards Lifesciences (NYSE:EW) S&P 500 Index Medical Device Presence - Kalkine Media

Jan 19, 2026
pulisher
Jan 19, 2026

Edwards Lifesciences Corporation (NYSE:EW) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 19, 2026
pulisher
Jan 18, 2026

Edwards Lifesciences Corporation (NYSE:EW) Short Interest Update - MarketBeat

Jan 18, 2026
pulisher
Jan 15, 2026

Edwards’ Heart Valve Clips Targeted by Cardiovalve Patent Suit - Bloomberg Law News

Jan 15, 2026
pulisher
Jan 15, 2026

Market Review: Whats the outlook for Edwards Lifesciences Corporations sectorPortfolio Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy - Benzinga

Jan 15, 2026
pulisher
Jan 14, 2026

Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing - Yahoo Finance

Jan 14, 2026
pulisher
Jan 14, 2026

Risk Report: Does Edwards Lifesciences Corporation align with a passive investing strategy2025 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

JPM26: Edwards Lifesciences targets 10% growth in 2026 - Yahoo Finance

Jan 14, 2026
pulisher
Jan 14, 2026

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? - Yahoo Finance

Jan 14, 2026
pulisher
Jan 13, 2026

Palmetto Grain Brokerage - Palmetto Grain Brokerage

Jan 13, 2026
pulisher
Jan 13, 2026

What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report - Yahoo Finance

Jan 13, 2026
pulisher
Jan 13, 2026

Nordea Investment Management AB Sells 110,464 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Spire Wealth Management Decreases Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Jan 13, 2026
pulisher
Jan 12, 2026

UBS Revises Edwards Lifesciences (EW) Price Target and Maintains Neutral Rating | EW Stock News - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

Barclays Raises Price Target for Edwards Lifesciences (EW) to $1 - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

FTC Blocks Edwards Lifesciences’ $945M JenaValve Acquisition - ocbj.com

Jan 12, 2026
pulisher
Jan 12, 2026

Edwards scraps Jenavalve buy in face of FTC objections - BioWorld MedTech

Jan 12, 2026
pulisher
Jan 12, 2026

Edwards Lifesciences (EW) Faces Legal Setback in Acquisition Pla - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

Edwards Lifesciences Corp Acquisition Blocked by FTC - TradingView — Track All Markets

Jan 12, 2026
pulisher
Jan 12, 2026

Hardman Johnston Global Advisors LLC Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Edwards Lifesciences Drops Bid to Acquire JenaValve Technology - marketscreener.com

Jan 12, 2026
pulisher
Jan 11, 2026

Oregon Public Employees Retirement Fund Increases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Jan 11, 2026
pulisher
Jan 10, 2026

Edwards won’t acquire JenaValve after FTC blocks deal - MassDevice

Jan 10, 2026
pulisher
Jan 10, 2026

Parnassus Investments LLC Takes $36.93 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat

Jan 10, 2026
pulisher
Jan 10, 2026

Edwards Lifesciences Explores Personalized Blood Pressure Targets in New Study - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve - Reuters

Jan 10, 2026
pulisher
Jan 09, 2026

FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve - Bitget

Jan 09, 2026
pulisher
Jan 09, 2026

Insider Selling: Edwards Lifesciences (NYSE:EW) VP Sells $87,328.30 in Stock - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Edwards Lifesciences (EW) Updates Earnings Guidance for 2023 - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Edwards Lifesciences (EW) Acquisition Blocked by Court - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Edwards says co will not acquire Jenavalve - marketscreener.com

Jan 09, 2026
pulisher
Jan 09, 2026

US court blocks heart valve deal; Edwards boosts outlook, backs therapy - Stock Titan

Jan 09, 2026
pulisher
Jan 09, 2026

Court sides with FTC to put Edwards Lifesciences’ JenaValve acquisition on hold - MassDevice

Jan 09, 2026
pulisher
Jan 09, 2026

Edwards Lifesciences (EW) CVP exercises options and sells 1,019 shares - Stock Titan

Jan 09, 2026

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$80.32
price up icon 0.06%
$73.67
price up icon 0.45%
medical_devices PHG
$29.52
price up icon 0.96%
medical_devices STE
$263.07
price down icon 0.02%
$264.91
price down icon 2.36%
大文字化:     |  ボリューム (24 時間):